Top 10 US Biotech/pharma Stocks To Buy For May And June

Given below is our list of 10 stocks that could see a run up over next 2 months due to up-coming catalysts:

1. Vascular Biogenics (VBLT): Interim results of the pivotal phase 3 trial of VB-111 in recurrent glioblastoma are expected in mid-2017 and full data will be available in early 2018. Link to...

Given below is our list of 10 stocks that could see a run up over next 2 months due to up-coming catalysts:

1. Vascular Biogenics (VBLT): Interim results of the pivotal phase 3 trial of VB-111 in recurrent glioblastoma are expected in mid-2017 and full data will be available in early 2018. Link to...

This article is only available to subscribers of Vasuda Healthcare Analytics
Learn more about Vasuda Healthcare Analytics